iBio, Inc.

iBio, Inc. develops pharmaceutical product applications using its iBio Technology platform; a platform that has proven to be more efficient and cost-effective than traditional systems. The iBioLaunch platform is a proprietary, transformative technology for the production of biologics including monoclonal antibodies, other therapeutic proteins, and vaccines.

More Client Stories

Former CEO, IsoRay

Dwight Babcock

CEO, Sonoma Pharmaceuticals

Jim Schutz

CEO, Payment Data Systems

Louis Hoch


We help you market your investment story with maximum impact and deliver your corporate message effectively

Contact Us
or call
+1 954 360 9998